APA (7th ed.) Citation

Nicholls, S. J., Nelson, A. J., Kastelein, J. J. P., Ditmarsch, M., Hsieh, A., Johnson, J., . . . Davidson, M. H. (2024). Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials. Pharmacology Research & Perspectives, 12(6), 1. https://doi.org/10.1002/prp2.70010

Chicago Style (17th ed.) Citation

Nicholls, Stephen J., et al. "Obicetrapib Exhibits Favorable Physiochemical and Pharmacokinetic Properties Compared to Previous Cholesteryl Ester Transfer Protein Inhibitors: An Integrated Summary of Results from Non‐human Primate Studies and Clinical Trials." Pharmacology Research & Perspectives 12, no. 6 (2024): 1. https://doi.org/10.1002/prp2.70010.

MLA (9th ed.) Citation

Nicholls, Stephen J., et al. "Obicetrapib Exhibits Favorable Physiochemical and Pharmacokinetic Properties Compared to Previous Cholesteryl Ester Transfer Protein Inhibitors: An Integrated Summary of Results from Non‐human Primate Studies and Clinical Trials." Pharmacology Research & Perspectives, vol. 12, no. 6, 2024, p. 1, https://doi.org/10.1002/prp2.70010.